122
TITLE: The origin and distribution of CRF50_A1D
AUTHORS: Foster, GM; Ambrose, JC; Conibear, TCR; Fearnhill, E; Abecasis, A; Asboe, D; Mackie, NE; Ustinowski, A; Leigh J L Brown; Geretti, AM;
PUBLISHED: 2011, SOURCE: International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies in ANTIVIRAL THERAPY, VOLUME: 16, ISSUE: 4
INDEXED IN: WOS
123
TITLE: Origin and Epidemiological History of HIV-1 CRF14_BG
AUTHORS: Inês Bártolo ; Ana B Abecasis; Pedro Borrego ; Helena Barroso ; Francine McCutchan; Perpétua Gomes ; Ricardo Camacho; Nuno Taveira ;
PUBLISHED: 2011, SOURCE: PLoS ONE, VOLUME: 6, ISSUE: 9
INDEXED IN: CrossRef Handle
IN MY: ORCID
124
TITLE: HIV-1 Genetic Diversity and Transmitted Drug Resistance in Health Care Settings in Maputo, Mozambique
AUTHORS: Inês Bártolo ; José Casanovas; Rui Bastos; Cheila Rocha; Ana B Abecasis; Elena Folgosa; José Mondlane; Rolanda Manuel; Nuno Taveira ;
PUBLISHED: 2009, SOURCE: JAIDS Journal of Acquired Immune Deficiency Syndromes, VOLUME: 51, ISSUE: 3
INDEXED IN: CrossRef
IN MY: ORCID
125
TITLE: HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments  Full Text
AUTHORS: Yung Shwen Ho; Ana B Abecasis; Kristof Theys; Koen Deforche; Dominic E Dwyer; Michael Charleston; Anne Mieke Vandamme; Nitin K Saksena;
PUBLISHED: 2008, SOURCE: VIROLOGY JOURNAL, VOLUME: 5, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
126
TITLE: Denial of expert opinion in HIV court cases
AUTHORS: Ana Abecasis; Anne Mieke Vandamme;
PUBLISHED: 2007, SOURCE: AIDS REVIEWS, VOLUME: 9, ISSUE: 4
INDEXED IN: WOS
127
TITLE: Rise and fall of the RT K65R incidence in the Portuguese resistance database
AUTHORS: Camacho, R; Theys, K; Abecasis, A; Deforche, K; Carvalho, AP; Cabanas, J; Gomes, P; Vandamme, AM;
PUBLISHED: 2006, SOURCE: 15th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 11, ISSUE: 5
INDEXED IN: WOS
128
TITLE: The in vivo selection of mutations L74I/V is linked to combined nucleoside reverse transcriptase and non-nucleoside reverse transcriptase inhibitor exposure
AUTHORS: Camacho, R; Theys, K; Abecasis, A; Deforche, K; Carvalho, AP; Cabanas, J; Gomes, P; Vandamme, AM;
PUBLISHED: 2006, SOURCE: 15th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 11, ISSUE: 5
INDEXED IN: WOS
129
TITLE: Different substitutions under drug pressure at protease codon 82 in HIV-1 subtype G compared to subtype B infected individuals including a novel 182M resistance mutation
AUTHORS: Camacho, R; Godinho, AR; Gomes, P; Abecasis, A; Vandamme, AM; Palma, C; Carvalho, AP; Cabanas, J; Goncalves, J;
PUBLISHED: 2005, SOURCE: 14th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 10, ISSUE: 4
INDEXED IN: WOS
130
TITLE: Role of HIV-1 protease residues 71 and 89 in protease inhibitor resistance of subtype G viruses
AUTHORS: Gonzalez, LMF; Van Laethem, K; Abecasis, AB; Soares, EAJM; Deforche, K; Vandamme, AM; Camacho, R; Soares, MA;
PUBLISHED: 2005, SOURCE: 14th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 10, ISSUE: 4
INDEXED IN: WOS
Page 13 of 14. Total results: 134.